| Acinetobacter baumannii |
Acinetobacter baumannii |
Inhibition |
6.42 |
% |
10.6019/CHEMBL4513141 |
| Bacillus subtilis |
4'-phosphopantetheinyl transferase ffp |
Potency |
28183.8 |
nM |
None |
| Bacillus subtilis |
4'-phosphopantetheinyl transferase ffp |
Potency |
44668.4 |
nM |
None |
| Candida albicans |
Candida albicans |
Inhibition |
1.32 |
% |
10.6019/CHEMBL4513141 |
| Canis lupus familiaris |
MDCK |
Activity |
nan |
None |
10.1021/jm3009844 |
| Cavia porcellus |
Cavia porcellus |
Incidence |
28.0 |
% |
10.1021/jm00363a015 |
| Cavia porcellus |
Cavia porcellus |
Incidence |
83.0 |
% |
10.1021/jm00363a015 |
| Cavia porcellus |
Cavia porcellus |
Mean score |
2.4 |
None |
10.1021/jm00363a015 |
| Cavia porcellus |
Cavia porcellus |
Weight loss |
12.0 |
g |
10.1021/jm00363a015 |
| Cryptococcus neoformans |
Cryptococcus neoformans |
Inhibition |
3.98 |
% |
10.6019/CHEMBL4513141 |
| Escherichia coli |
Escherichia coli |
Inhibition |
3.21 |
% |
10.6019/CHEMBL4513141 |
| Escherichia coli |
GroEL/GroES |
IC50 |
490.0 |
nM |
10.1016/j.bmcl.2019.02.028 |
| Escherichia coli |
GroEL/GroES |
IC50 |
6000.0 |
nM |
10.1016/j.bmcl.2019.02.028 |
| Escherichia coli |
GroEL/GroES |
Inhibition |
49.0 |
% |
10.1016/j.bmcl.2019.02.028 |
| Escherichia coli |
GroEL/GroES |
Inhibition |
87.0 |
% |
10.1016/j.bmcl.2019.02.028 |
| Escherichia coli K-12 |
Beta-lactamase AmpC |
Inhibition |
5.0 |
% |
10.1021/jm030191r |
| Escherichia coli (strain K12) |
60 kDa chaperonin |
IC50 |
250000.0 |
nM |
10.1016/j.bmcl.2019.02.028 |
| Giardia intestinalis |
Putative fructose-1,6-bisphosphate aldolase |
Potency |
3539.7 |
nM |
None |
| Homo sapiens |
15-hydroxyprostaglandin dehydrogenase [NAD+] |
Potency |
11220.2 |
nM |
None |
| Homo sapiens |
Acetylcholinesterase |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Aldehyde dehydrogenase 1A1 |
Potency |
8912.5 |
nM |
None |
| Homo sapiens |
Aldehyde dehydrogenase 1A1 |
Potency |
14988.9 |
nM |
None |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Androgen Receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Arachidonate 15-lipoxygenase |
Potency |
15848.9 |
nM |
None |
| Homo sapiens |
Arachidonate 15-lipoxygenase |
Potency |
31622.8 |
nM |
None |
| Homo sapiens |
Ataxin-2 |
Potency |
17782.8 |
nM |
None |
| Homo sapiens |
ATP-dependent DNA helicase Q1 |
Potency |
3981.1 |
nM |
None |
| Homo sapiens |
ATP-dependent DNA helicase Q1 |
Potency |
7079.5 |
nM |
None |
| Homo sapiens |
Bile salt export pump |
AC50 |
300000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bile salt export pump |
IC50 |
381000.0 |
nM |
10.1124/dmd.112.047068 |
| Homo sapiens |
Breast cancer type 1 susceptibility protein |
Potency |
15848.9 |
nM |
None |
| Homo sapiens |
Canalicular multispecific organic anion transporter 1 |
Activity |
109.0 |
% |
10.1021/jm7015683 |
| Homo sapiens |
Caspase-1 |
Potency |
6309.6 |
nM |
None |
| Homo sapiens |
Caspase-1 |
Potency |
12589.3 |
nM |
None |
| Homo sapiens |
Caspase-7 |
Potency |
7943.3 |
nM |
None |
| Homo sapiens |
Caspase-7 |
Potency |
25118.9 |
nM |
None |
| Homo sapiens |
Chymotrypsin C |
Inhibition |
5.0 |
% |
10.1021/jm030191r |
| Homo sapiens |
Cyclooxygenase-1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-2 |
IC50 |
7530.0 |
nM |
10.1016/j.ejmech.2019.07.016 |
| Homo sapiens |
Cystathionine gamma-lyase |
IC50 |
200000.0 |
nM |
10.1021/acs.jmedchem.8b01720 |
| Homo sapiens |
Cystine/glutamate transporter |
IC50 |
1000000.0 |
nM |
10.1016/j.bmcl.2011.07.081 |
| Homo sapiens |
Cytochrome P450 1A2 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
AC50 |
5011.87 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
Potency |
5011.9 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
AC50 |
12589.25 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
Potency |
12589.3 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
AC50 |
7943.28 |
nM |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
Potency |
7943.3 |
nM |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
DNA-(apurinic or apyrimidinic site) lyase |
Potency |
1995.3 |
nM |
None |
| Homo sapiens |
DNA-(apurinic or apyrimidinic site) lyase |
Potency |
7079.5 |
nM |
None |
| Homo sapiens |
DNA polymerase kappa |
Potency |
1062.1 |
nM |
None |
| Homo sapiens |
DNA polymerase kappa |
Potency |
5972.8 |
nM |
None |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Endoplasmic reticulum-associated amyloid beta-peptide-binding protein |
Potency |
10000.0 |
nM |
None |
| Homo sapiens |
Endoplasmic reticulum-associated amyloid beta-peptide-binding protein |
Potency |
15848.9 |
nM |
None |
| Homo sapiens |
Endoplasmic reticulum-associated amyloid beta-peptide-binding protein |
Potency |
31622.8 |
nM |
None |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Gamma-aminobutyric acid receptor subunit alpha-1/alpha-2/beta-2/gamma-2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glutaminase kidney isoform, mitochondrial |
Potency |
15848.9 |
nM |
None |
| Homo sapiens |
HEK293 |
Activity |
35.5 |
% |
10.1016/j.bmc.2017.03.024 |
| Homo sapiens |
HEK293 |
IC50 |
15000000.0 |
nM |
10.1016/j.bmc.2017.03.024 |
| Homo sapiens |
HERG |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histone acetyltransferase GCN5 |
Potency |
7943.3 |
nM |
None |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
0.62 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
2.81 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 |
Potency |
3162.3 |
nM |
None |
| Homo sapiens |
Homo sapiens |
DILI_Concern |
nan |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
DILI_severity_class |
7.0 |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
F |
28.0 |
% |
10.1021/jm901421c |
| Homo sapiens |
HSP60/HSP10 |
IC50 |
12000.0 |
nM |
10.1016/j.bmcl.2019.02.028 |
| Homo sapiens |
HT-29 |
IC50 |
20000000.0 |
nM |
10.1016/j.ejmech.2020.113149 |
| Homo sapiens |
HT-29 |
IC50 |
20400000.0 |
nM |
10.1016/j.ejmech.2017.06.018 |
| Homo sapiens |
HT-29 |
Inhibition |
3.5 |
% |
10.1039/C8MD00156A |
| Homo sapiens |
HT-29 |
Inhibition |
3.7 |
% |
10.1016/j.ejmech.2017.06.018 |
| Homo sapiens |
HT-29 |
Inhibition |
50.5 |
% |
10.1039/C8MD00156A |
| Homo sapiens |
HT-29 |
Inhibition |
52.8 |
% |
10.1016/j.ejmech.2017.06.018 |
| Homo sapiens |
HT-29 |
Inhibition |
nan |
% |
10.1016/j.ejmech.2017.06.018 |
| Homo sapiens |
Hypoxia-inducible factor 1 alpha |
Potency |
10000.0 |
nM |
None |
| Homo sapiens |
Lysine-specific demethylase 4D-like |
Potency |
3981.1 |
nM |
None |
| Homo sapiens |
Menin/Histone-lysine N-methyltransferase MLL |
Potency |
12589.3 |
nM |
None |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Pendrin |
Activity |
nan |
None |
10.1016/j.bmc.2017.03.024 |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Progesterone receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Protein-arginine deiminase type-4 |
IC50 |
10000000.0 |
nM |
10.1016/j.bmc.2007.10.021 |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1A2 |
Inhibition |
nan |
% |
10.1124/dmd.110.034991 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B1 |
Drug uptake |
nan |
None |
10.1124/dmd.110.034991 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B1 |
FC |
2.7 |
None |
10.1124/dmd.110.034991 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B1 |
Inhibition |
nan |
% |
10.1124/dmd.110.034991 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B1 |
Km |
55100.0 |
nM |
10.1124/dmd.110.034991 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B1 |
Vmax |
28.3 |
pmol/min |
10.1124/dmd.110.034991 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B3 |
Drug uptake |
nan |
None |
10.1124/dmd.110.034991 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B3 |
FC |
2.9 |
None |
10.1124/dmd.110.034991 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B3 |
Inhibition |
nan |
% |
10.1124/dmd.110.034991 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B3 |
Km |
77400.0 |
nM |
10.1124/dmd.110.034991 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B3 |
Vmax |
85.1 |
pmol/min |
10.1124/dmd.110.034991 |
| Homo sapiens |
Solute carrier organic anion transporter family member 2B1 |
Drug uptake |
nan |
None |
10.1124/dmd.110.034991 |
| Homo sapiens |
Solute carrier organic anion transporter family member 2B1 |
FC |
2.0 |
None |
10.1124/dmd.110.034991 |
| Homo sapiens |
Solute carrier organic anion transporter family member 2B1 |
Inhibition |
nan |
% |
10.1124/dmd.110.034991 |
| Homo sapiens |
Solute carrier organic anion transporter family member 2B1 |
Km |
188900.0 |
nM |
10.1124/dmd.110.034991 |
| Homo sapiens |
Solute carrier organic anion transporter family member 2B1 |
Vmax |
37.2 |
pmol/min |
10.1124/dmd.110.034991 |
| Homo sapiens |
Thiosulfate sulfurtransferase |
IC50 |
280.0 |
nM |
10.1016/j.bmcl.2019.02.028 |
| Homo sapiens |
Thrombin |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thyroid hormone receptor beta-1 |
Potency |
14125.4 |
nM |
None |
| Homo sapiens |
Thyroid hormone receptor beta-1 |
Potency |
125892.5 |
nM |
None |
| Homo sapiens |
TNF-alpha |
IC50 |
20000.0 |
nM |
10.1039/C8MD00156A |
| Homo sapiens |
TNF-alpha |
IC50 |
20600000.0 |
nM |
10.1016/j.bmcl.2018.06.012 |
| Homo sapiens |
TNF-alpha |
Inhibition |
52.1 |
% |
10.1016/j.bmcl.2018.06.012 |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
1000.0 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
2511.9 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
11220.2 |
nM |
None |
| Homo sapiens |
Ubiquitin carboxyl-terminal hydrolase 1 |
Potency |
11220.2 |
nM |
None |
| Homo sapiens |
Ubiquitin carboxyl-terminal hydrolase 1 |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
UDP-glucuronosyltransferase 1-6 |
Activity |
0.0 |
pm/min/mg |
10.1146/annurev.pharmtox.40.1.581 |
| Homo sapiens |
UDP-glucuronosyltransferase 1-9 |
Activity |
0.0 |
pm/min/mg |
10.1146/annurev.pharmtox.40.1.581 |
| Homo sapiens |
Vascular endothelial growth factor receptor 2 |
AC50 |
16088.3 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vitamin D receptor |
Potency |
44668.4 |
nM |
None |
| Influenza A virus |
Influenza A virus |
Activity |
nan |
None |
10.1021/jm3009844 |
| Influenza A virus |
Influenza A virus |
EC50 |
100000.0 |
nM |
10.1021/jm3009844 |
| Influenza A virus (strain A/Wilson-Smith/1933 H1N1) (Influenza A virus(strain A/WS/1933 H1N1)) |
Neuraminidase |
IC50 |
100000.0 |
nM |
10.1021/jm3009844 |
| Klebsiella pneumoniae |
Klebsiella pneumoniae |
Inhibition |
-2.18 |
% |
10.6019/CHEMBL4513141 |
| Mus musculus |
Epidermal growth factor receptor erbB1 |
IC50 |
2.7 |
ug.mL-1 |
10.1021/np50066a009 |
| Mus musculus |
Hydroxyacid oxidase 1 |
FC |
0.88 |
None |
10.1021/acs.jmedchem.8b00399 |
| Mus musculus |
Hydroxyacid oxidase 1 |
IC50 |
7800.0 |
nM |
10.1021/acs.jmedchem.8b00399 |
| Mus musculus |
Hydroxyacid oxidase 1 |
Inhibition |
71.9 |
% |
10.1021/acs.jmedchem.8b00399 |
| Mus musculus |
Mus musculus |
Activity |
3.0 |
None |
10.1021/acs.jmedchem.1c02198 |
| Mus musculus |
Mus musculus |
Activity |
5.9 |
% |
10.1016/j.bmcl.2021.127844 |
| Mus musculus |
Mus musculus |
Activity |
7.15 |
cm |
10.1016/j.ejmech.2019.04.031 |
| Mus musculus |
Mus musculus |
Activity |
7.7 |
% |
10.1016/j.bmcl.2021.127844 |
| Mus musculus |
Mus musculus |
Activity |
9.59 |
% |
10.1016/j.bmcl.2021.127844 |
| Mus musculus |
Mus musculus |
Activity |
11.69 |
% |
10.1021/acs.jmedchem.2c00390 |
| Mus musculus |
Mus musculus |
Activity |
17.1 |
% |
10.1021/acs.jmedchem.1c02198 |
| Mus musculus |
Mus musculus |
Activity |
18.32 |
g |
10.1016/j.bmc.2016.05.047 |
| Mus musculus |
Mus musculus |
Activity |
19.1 |
% |
10.1021/jm3008568 |
| Mus musculus |
Mus musculus |
Activity |
25.0 |
% |
10.1021/acs.jmedchem.1c02198 |
| Mus musculus |
Mus musculus |
Activity |
27.5 |
% |
10.1021/acs.jmedchem.1c02198 |
| Mus musculus |
Mus musculus |
Activity |
30.1 |
% |
10.1021/acs.jmedchem.1c02198 |
| Mus musculus |
Mus musculus |
Activity |
32.4 |
% |
10.1021/acs.jmedchem.1c02198 |
| Mus musculus |
Mus musculus |
Activity |
36.9 |
% |
10.1021/acs.jmedchem.1c02198 |
| Mus musculus |
Mus musculus |
Activity |
38.3 |
% |
10.1021/acs.jmedchem.1c02198 |
| Mus musculus |
Mus musculus |
Activity |
39.4 |
% |
10.1021/acs.jmedchem.1c02198 |
| Mus musculus |
Mus musculus |
Activity |
42.2 |
% |
10.1021/acs.jmedchem.1c02198 |
| Mus musculus |
Mus musculus |
Activity |
43.2 |
% |
10.1021/acs.jmedchem.1c02198 |
| Mus musculus |
Mus musculus |
Activity |
44.0 |
% |
10.1021/acs.jmedchem.1c02198 |
| Mus musculus |
Mus musculus |
Activity |
44.3 |
% |
10.1021/acs.jmedchem.1c02198 |
| Mus musculus |
Mus musculus |
Activity |
46.0 |
% |
10.1021/acs.jmedchem.1c02198 |
| Mus musculus |
Mus musculus |
Activity |
46.3 |
% |
10.1021/acs.jmedchem.1c02198 |
| Mus musculus |
Mus musculus |
Activity |
47.3 |
% |
10.1021/acs.jmedchem.1c02198 |
| Mus musculus |
Mus musculus |
Activity |
48.7 |
% |
10.1021/acs.jmedchem.1c02198 |
| Mus musculus |
Mus musculus |
Activity |
53.4 |
mm |
10.1016/j.bmc.2016.05.047 |
| Mus musculus |
Mus musculus |
Activity |
53.5 |
% |
10.1021/acs.jmedchem.1c02198 |
| Mus musculus |
Mus musculus |
Activity |
54.7 |
% |
10.1021/acs.jmedchem.1c02198 |
| Mus musculus |
Mus musculus |
Activity |
54.9 |
% |
10.1021/acs.jmedchem.1c02198 |
| Mus musculus |
Mus musculus |
Activity |
55.7 |
% |
10.1021/acs.jmedchem.1c02198 |
| Mus musculus |
Mus musculus |
Activity |
78.2 |
% |
10.1021/acs.jmedchem.1c02198 |
| Mus musculus |
Mus musculus |
Activity |
84.4 |
% |
10.1021/acs.jmedchem.1c02198 |
| Mus musculus |
Mus musculus |
Activity |
nan |
None |
10.1016/j.bmc.2016.05.047 |
| Mus musculus |
Mus musculus |
Activity |
nan |
None |
10.1016/j.bmcl.2021.127844 |
| Mus musculus |
Mus musculus |
Activity |
nan |
None |
10.1021/acs.jmedchem.1c02198 |
| Mus musculus |
Mus musculus |
Activity |
nan |
None |
10.1021/acs.jmedchem.2c00390 |
| Mus musculus |
Mus musculus |
Activity |
nan |
None |
10.1021/acs.jmedchem.9b01663 |
| Mus musculus |
Mus musculus |
Inhibition |
nan |
% |
10.1016/j.bmc.2011.04.057 |
| Mus musculus |
Mus musculus |
Inhibition |
nan |
% |
10.1016/j.bmc.2016.05.047 |
| Mus musculus |
Mus musculus |
Inhibition |
nan |
% |
10.1016/j.ejmech.2013.01.024 |
| Mus musculus |
RAW264.7 |
Activity |
nan |
None |
10.1021/jm3009844 |
| Mycobacterium avium subsp. paratuberculosis |
Mycobacterium avium subsp. paratuberculosis |
Activity |
64.0 |
ug ml-1 |
10.1128/aac.00678-07 |
| Mycobacterium avium subsp. paratuberculosis |
Mycobacterium avium subsp. paratuberculosis |
Activity |
nan |
None |
10.1128/aac.00678-07 |
| Ovis aries |
Cyclooxygenase-1 |
IC50 |
7730.0 |
nM |
10.1016/j.ejmech.2019.07.016 |
| Photinus pyralis |
Luciferin 4-monooxygenase |
Potency |
32196.8 |
nM |
None |
| Pseudomonas aeruginosa |
Pseudomonas aeruginosa |
Inhibition |
3.43 |
% |
10.6019/CHEMBL4513141 |
| Rattus norvegicus |
Colon |
Activity |
60.85 |
MU |
10.1016/j.ejmech.2006.11.017 |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
47.0 |
% |
10.1016/j.ejmech.2009.04.018 |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
60.85 |
mU |
10.1016/j.ejmech.2008.03.035 |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
88.0 |
% |
10.1016/j.bmcl.2021.128029 |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
nan |
None |
10.1016/j.bmcl.2007.01.031 |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
nan |
None |
10.1016/j.bmcl.2021.128029 |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
nan |
None |
10.1016/j.ejmech.2008.03.035 |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
nan |
None |
10.1016/j.ejmech.2011.11.030 |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
nan |
None |
10.1016/j.ejmech.2015.12.021 |
| Rattus norvegicus |
Rattus norvegicus |
FC |
93.8 |
None |
10.1016/j.bmcl.2015.04.023 |
| Rattus norvegicus |
Rattus norvegicus |
Fecal recovery |
4.32 |
% |
10.1021/jm00078a009 |
| Rattus norvegicus |
Rattus norvegicus |
Fecal recovery |
5.08 |
% |
10.1021/jm00078a009 |
| Rattus norvegicus |
Rattus norvegicus |
Inhibition |
12.0 |
% |
10.1016/j.ejmech.2006.11.017 |
| Rattus norvegicus |
Rattus norvegicus |
Inhibition |
38.6 |
% |
10.1016/j.bmcl.2015.04.023 |
| Rattus norvegicus |
Rattus norvegicus |
Inhibition |
47.0 |
% |
10.1016/j.ejmech.2006.11.017 |
| Rattus norvegicus |
Rattus norvegicus |
Inhibition |
50.0 |
% |
10.1016/j.ejmech.2014.10.081 |
| Rattus norvegicus |
Rattus norvegicus |
Inhibition |
52.3 |
% |
10.1016/j.bmcl.2015.04.023 |
| Rattus norvegicus |
Rattus norvegicus |
Inhibition |
53.2 |
% |
10.1016/j.bmcl.2015.04.023 |
| Rattus norvegicus |
Rattus norvegicus |
Inhibition |
57.5 |
% |
10.1016/j.bmcl.2015.04.023 |
| Rattus norvegicus |
Rattus norvegicus |
Inhibition |
63.8 |
% |
10.1016/j.bmcl.2015.04.023 |
| Rattus norvegicus |
Rattus norvegicus |
Inhibition |
nan |
% |
10.1016/j.ejmech.2015.12.021 |
| Rattus norvegicus |
Rattus norvegicus |
pLD50 |
7.94 |
None |
10.1007/s00044-009-9162-3 |
| Rattus norvegicus |
Rattus norvegicus |
UI |
59.6 |
None |
10.1016/j.bmc.2007.04.045 |
| Rattus norvegicus |
Rattus norvegicus |
UI |
59.6 |
None |
10.1016/j.bmcl.2007.01.031 |
| Rattus norvegicus |
Rattus norvegicus |
UI |
60.03 |
None |
10.1016/j.ejmech.2006.11.017 |
| Rattus norvegicus |
Rattus norvegicus |
UI |
60.03 |
None |
10.1016/j.ejmech.2008.03.035 |
| Rattus norvegicus |
Rattus norvegicus |
UI |
60.03 |
None |
10.1016/j.ejmech.2009.04.018 |
| Rattus norvegicus |
Rattus norvegicus |
Urinary recovery |
69.61 |
% |
10.1021/jm00078a009 |
| Rattus norvegicus |
Rattus norvegicus |
Urinary recovery |
78.84 |
% |
10.1021/jm00078a009 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
7.437 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Hit score |
0.1964 |
None |
10.1101/2020.04.21.054387 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
19952.62 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
20000.0 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
-4.82 |
% |
10.21203/rs.3.rs-23951/v1 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
-0.12 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition index |
0.3772 |
None |
10.1101/2020.04.03.023846 |
| Simian virus 40 |
Large T antigen |
IC50 |
19100.0 |
nM |
None |
| Staphylococcus aureus |
Staphylococcus aureus |
Inhibition |
-19.58 |
% |
10.6019/CHEMBL4513141 |
| Sus scrofa |
Malate dehydrogenase mitochondrial |
Inhibition |
18.0 |
% |
10.1021/jm030191r |
| None |
ADMET |
CL |
9.3 |
mL.min-1.kg-1 |
10.1124/dmd.108.020479 |
| None |
ADMET |
Drugexcretion |
25.0 |
% |
10.1136/gut.39.1.63 |
| None |
ADMET |
Km |
16300.0 |
nM |
10.1124/dmd.110.034991 |
| None |
ADMET |
Km |
24300.0 |
nM |
10.1124/dmd.110.034991 |
| None |
ADMET |
Km |
32400.0 |
nM |
10.1124/dmd.110.034991 |
| None |
ADMET |
Km |
55100.0 |
nM |
10.1124/dmd.110.034991 |
| None |
ADMET |
MRT |
0.59 |
hr |
10.1124/dmd.108.020479 |
| None |
ADMET |
permeability |
0.9 |
10'-6 cm/s |
10.1021/jm901421c |
| None |
ADMET |
T1/2 |
0.61 |
hr |
10.1124/dmd.108.020479 |
| None |
ADMET |
Vdss |
0.33 |
L.kg-1 |
10.1124/dmd.108.020479 |
| None |
ADMET |
Vmax |
3.8 |
pmol/min |
10.1124/dmd.110.034991 |
| None |
ADMET |
Vmax |
6.1 |
pmol/min |
10.1124/dmd.110.034991 |
| None |
ADMET |
Vmax |
9.3 |
pmol/min |
10.1124/dmd.110.034991 |
| None |
ADMET |
Vmax |
28.3 |
pmol/min |
10.1124/dmd.110.034991 |
| None |
Hepatotoxicity |
Alkaline Phosphatase Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Alkaline Phosphatase Increase - Index Value |
1.3 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Alkaline Phosphatase Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Composite Activity - Active |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Composite Activity - Marginal |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Composite Activity - Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
GGT Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
GGT Increase - Index Value |
1.5 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
GGT Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1021/tx900326k |
| None |
Hepatotoxicity |
HepSE_bilirubinemia |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholecystitis |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholelithiasis |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cirrhosis |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_Combined Scores |
8.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_elevated liver function tests |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic failure |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic necrosis |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatitis |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatomegaly |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_jaundice |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver disease |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver fatty |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver function tests abnormal |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
LDH Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
LDH Increase - Index Value |
1.1 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
LDH Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGOT Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGOT Increase - Index Value |
2.2 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGOT Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGPT Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGPT Increase - Index Value |
1.8 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGPT Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Macrophage |
Activity |
nan |
None |
10.1016/j.ejmech.2013.01.024 |
| None |
NON-PROTEIN TARGET |
Fu |
0.39 |
None |
10.1124/dmd.108.020479 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (acute) |
1.0 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (animal toxicity known) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (benign tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (granulomatous hepatitis) |
1.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (mechanism) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
14.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
21.0 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (time to onset) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
IC50 |
16000000.0 |
nM |
10.1016/j.ejmech.2011.09.008 |
| None |
NON-PROTEIN TARGET |
IC50 |
18100000.0 |
nM |
10.1016/j.bmcl.2016.08.075 |
| None |
NON-PROTEIN TARGET |
Inhibition |
3.8 |
% |
10.1016/j.bmcl.2016.08.075 |
| None |
NON-PROTEIN TARGET |
Inhibition |
52.7 |
% |
10.1016/j.bmcl.2016.08.075 |
| None |
No relevant target |
Activity |
nan |
None |
10.1016/j.bmcl.2015.07.001 |
| None |
No relevant target |
LogP |
0.64 |
None |
10.1016/j.bmc.2007.04.045 |
| None |
No relevant target |
LogP |
0.64 |
None |
10.1016/j.bmcl.2007.01.031 |
| None |
No relevant target |
LogP |
0.64 |
None |
10.1016/j.ejmech.2006.11.017 |
| None |
No relevant target |
LogP |
0.64 |
None |
10.1016/j.ejmech.2009.04.018 |
| None |
No relevant target |
Solubility |
1850.0 |
ug.mL-1 |
10.1016/j.ejmech.2009.04.018 |
| None |
Unchecked |
Ac50 |
0.2818 |
uM |
None |
| None |
Unchecked |
Ac50 |
0.7079 |
uM |
None |
| None |
Unchecked |
Ac50 |
2.239 |
uM |
None |
| None |
Unchecked |
Ac50 |
28.18 |
uM |
None |
| None |
Unchecked |
Ac50 |
31.62 |
uM |
None |
| None |
Unchecked |
AC50 |
281.8 |
nM |
None |
| None |
Unchecked |
AC50 |
707.9 |
nM |
None |
| None |
Unchecked |
AC50 |
2238.7 |
nM |
None |
| None |
Unchecked |
AC50 |
28183.8 |
nM |
None |
| None |
Unchecked |
AC50 |
28190.0 |
nM |
None |
| None |
Unchecked |
AC50 |
31622.8 |
nM |
None |
| None |
Unchecked |
Hepatotoxicity (acute) |
12.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (association with vascular disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (choleostasis) |
3.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (chronic liver disease) |
1.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cirrhosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (comment) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cytolytic) |
5.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (malignant tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (severe hepatitis) |
1.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (steatosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (successful reintroduction) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
IC50 |
8290.0 |
nM |
None |
| None |
Unchecked |
IC50 |
63000.0 |
nM |
10.1016/j.bmcl.2019.02.028 |
| None |
Unchecked |
Inhibition |
1.7 |
% |
10.1016/j.bmcl.2021.128059 |
| None |
Unchecked |
Inhibition |
9.9 |
% |
10.1016/j.bmcl.2021.128059 |
| None |
Unchecked |
Inhibition |
nan |
% |
10.1016/j.ejmech.2011.11.030 |
| None |
Unchecked |
Potency |
14125.4 |
nM |
None |
| None |
Unchecked |
Potency |
17782.8 |
nM |
None |
| None |
Unchecked |
Ratio IC50 |
1.02 |
None |
10.1016/j.ejmech.2019.07.016 |